DysphoniaNCT07176988
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
A study testing Hierarchical method and Non Hierarchical method in people with Dysphonia and Primary Muscle Tension Dysphonia (MTD), run by Emory University at 1 site in United States.
Trial summary
This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction… Read more about this study
- Who is it for?
- Ages 16 to 65 years
- Conditions the study is for
- Dysphonia, Primary Muscle Tension Dysphonia (MTD)
- What is being tested?
- Hierarchical method and Non Hierarchical method
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Sep 2025to Apr 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 65 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Non-smoking
- Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
- No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
- No history of voice therapy or voice surgery in the last year
- No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist,
- Willingness to attend all therapeutic interventions and follow-up sessions
- Willingness to use a smartphone to record practice
Who cannot join
- History of voice therapy or voice surgery in the last year
- Serious chronic medical condition that may affect voice (per patient report)
- Abnormal hearing ability (despite appropriate amplification)
- Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
- Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
- Unwillingness to attend therapeutic intervention and follow-up sessions
Show all 10Show fewer
- Unwillingness to use a smartphone to record practice
- Pregnant women
- Prisoners
- Cognitive impairment or impaired decision-making capacity
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Emory Voice Center at Emory University Hospital Midtown
Atlanta, Georgia, 30308
Amanda Gillespie, PhD, 404-778-3381, amanda.i.gillespie@emory.edu
About this study
This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions).
The secondary objectives are:
- To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes.
- To determine the association between overall dysphonia outcomes and adoption of clear speech.
Read the detailed description
About 23 million Americans-roughly 1 in 13 people-suffer from voice problems at any given time. These issues can make it hard to speak clearly, lead to throat pain or fatigue, and affect daily life, work, and emotional well-being. The two most common types of voice problems are:
- Muscle tension dysphonia (MTD): when muscles in the throat are too tight during speaking.
- Benign vocal fold lesions: such as nodules or swelling on the vocal cords due to overuse or strain.
The most common treatment for these conditions is behavioral voice therapy, which involves working with a speech-language pathologist (SLP) to learn new ways to use the voice. However, over a third of patients drop out, and long-term success is uncertain. One major challenge is helping patients apply what they learn in therapy to their real-life conversations-a step often saved for the end of treatment or skipped entirely.
Traditional voice therapies often follow a strict step-by-step ("hierarchical") approach. Patients start with basic sounds or exercises and only work up to everyday speech later. But this method may not be the most effective, and many people struggle to use the new techniques outside the clinic.
To solve this problem, the research team developed a new method called Conversation Training Therapy (CTT). CTT flips the traditional approach: it begins with practicing clear, intentional speech in real conversation from the first session. This helps patients immediately apply new voice skills in real-life situations, which may lead to faster, more lasting results.
Studies have shown that CTT leads to meaningful improvements in voice-related quality of life both immediately and up to three months after therapy. It is now being used in national research studies and has gained recognition as a promising, evidence-based therapy. The current research will compare CTT to traditional methods over a full year, helping to answer important questions about what makes voice therapy work-and how to help more people benefit from it long-term.
- Conditions
- Dysphonia, Primary Muscle Tension Dysphonia (MTD)
- Being tested
- Hierarchical method, Non Hierarchical method
- Keywords
- Conversation Training Therapy, Hierarchical Conversation Training Therapy, primary muscle tension dysphonia, benign vocal fold lesions
- Medical subject headings
- Dysphonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hierarchical methodOther
Participants in the hierarchical version of Conversation Training Therapy (CTTH) will receive four weekly sessions of voice therapy. This approach gradually increases the difficulty of speaking tasks-from simple sounds to full conversations-based on the participant's progress. The therapy begins with basic awareness and speech sounds (e.g., consonant-vowel pairs), then progresses through words, phrases, and sentences, culminating in natural conversation. Each level must be completed with at least 80% accuracy before proceeding to the next one.
The structure is modeled after traditional voice therapies like resonant voice and aims to help participants succeed early and reduce mental fatigue. Daily homework includes seven short (2.5-minute) practice sessions, aligned with prior research showing this is a realistic and effective amount of practice.
Non Hierarchical methodOther
The therapy includes four weekly sessions and several key techniques:
Clear Speech: Speaking clearly, like leaving an important voicemail.
Awareness Training: Paying attention to how the voice sounds and feels in the mouth and face.
Negative Practice: Switching between their "bad" voice and "good" therapy voice to recognize and improve differences.
Embedded Gestures: Briefly holding certain speech sounds to reduce vocal strain and boost clarity.
Prosody and Projection: Working on pitch, rhythm, and speaking louder through better technique.
Participants practice these skills throughout the day using a mobile app to track their progress and record a weekly sample. Unlike hierarchical models, components in CTT can be introduced in any order based on individual needs, making it flexible and personalized
| Study group | Role | What they receive |
|---|---|---|
| Non-Hierarchical Conversation Training Therapy (CTT) | Experimental | Not described Receives: Other: Non Hierarchical method |
| Hierarchical Conversation Training Therapy (CTT-H) | Experimental | Not described Receives: Other: Hierarchical method |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Voice Handicap Index-10 (VHI-10) score
The Voice Handicap Index-10 (VHI-10) is a 10-question survey used to measure how much a voice problem affects a person's daily life. Scores range from 0 to 40, with higher scores indicating a greater perceived voice handicap. Each item is rated from 0 ("never") to 4 ("always") A higher score means greater voice-related disability as perceived by the patient.
Measured: During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment
Change in vowel space
Change in vowel space refers to alterations in the acoustic range of vowel production-specifically, how far apart vowels are from each other in the formant frequency space (typically plotted as F1 vs F2, the first and second formants). It reflects the clarity, precision, and distinctiveness of vowel articulation during speech.
Vowel space will be measured through acoustic analysis of participants' spoken sentences from the Sentence Intelligibility Test (SIT).
These sentences include both corner vowels (e.g., heed, had, hod, who'd) and non-corner vowels (e.g., hid, head, hut, hood), allowing for detailed tracking of articulatory patterns
Measured: During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment.
Secondary outcomes (13)
Auditory- Perceptual severity
It is measured using the CAPE-V (Consensus Auditory-Perceptual Evaluation of Voice) scale, a standardized tool.
Raters (blinded speech-language pathologists) will score overall voice severity on a 0-100 mm visual analog scale-with 0 indicating no perceived disorder and 100 indicating extremely severe voice abnormality.
This rating captures a listener's perception of qualities like roughness, breathiness, strain, and overall voice quality.
Measured: Baseline , 3 month, 6 month, 12 month
Stroboscopic changes: Glottal Closure
Visual inspection during phonation. Described as: complete, anterior gap, posterior gap, hourglass, spindle, irregular, incomplete.
Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Amplitude
Observed lateral movement of vocal folds. Subjectively rated as reduced, normal, or excessive. Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Mucosal Wave
Magnitude of mucosal membrane during vibration. Scored on a 0-10 scale based on visibility and extent Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Free edge contour
Shape of vocal fold edges during vibration. Rated as: normal, convex, concave, irregular, or rough Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Phase closure
Duration of open vs. closed phase during each vibratory cycle. Rated as: open phase dominates, equal, closed phase dominates Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Phase symmetry
Synchrony of left and right vocal fold movement. Rated as: symmetric or asymmetric Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Regularity percentage
Consistency of vibratory cycles over time. Expressed as % of time vibration is regular Assessments will be made using a standardized tool called VALI (Voice-Vibratory Assessment with Laryngeal Imaging), which scores multiple vibratory features.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average airflow in speech
Average airflow in speech - measures how much air passes through the vocal folds per second during phonation (typically in liters/second or mL/second). Abnormal airflow can indicate vocal fold dysfunction, such as incomplete closure or excessive strain.
This data will be collected using the Phonatory Aerodynamic System 6600 (PAS) by PENTAX, a specialized tool for assessing voice aerodynamics. The PAS system uses a mask and microphone setup to capture airflow and sound pressure during structured speech tasks.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average number of breaths
Average number of breaths - counts how many breaths a speaker takes during a speech task. Higher breath counts may reflect inefficient voice use or reduced respiratory support.
This data will be collected using the Phonatory Aerodynamic System 6600 (PAS) by PENTAX, a specialized tool for assessing voice aerodynamics. The PAS system uses a mask and microphone setup to capture airflow and sound pressure during structured speech tasks.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average speaking duration
Speaking duration is how long it takes the person to speak the entire passage. This data will be collected using the Phonatory Aerodynamic System 6600 (PAS) by PENTAX, a specialized tool for assessing voice aerodynamics. The PAS system uses a mask and microphone setup to capture airflow and sound pressure during structured speech tasks.
Measured: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Adherence
Practice will be analyzed for frequency of practice per week
Measured: Baseline, end of study (12 month)
Practice fidelity
Practice fidelity will be assessed via analysis of audio-recordings for presence/absence of negative practice and type of practice (i.e. conversation, monology, recitation, reading aloud).
Measured: Baseline, end of study (12 month)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2025
- Study start3 Sep 2025
- Primary completionApr 2029 (estimated)
- Study completionApr 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DysphoniaStudies of the same condition, open and under way.
- More trials run by Emory UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Subjects will be assigned based on a stratified block randomization based on diagnosis (MTD, lesions), severity (mild, moderate, severe), and sex
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Emory University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Responsible party
- Principal investigator, Amanda Gillespie, Emory University
- Investigators
- Amanda Gillespie, PhD, Principal investigator, Emory University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07176988
- Sponsor's protocol ID
- STUDY00009121
- Other IDs
- 1R01DC022026-01A1
- Status last verified
- Oct 2025
- First submitted
- 18 Aug 2025
- Last updated
- 20 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: This project will generate multi-modal data from 120 participants with voice disorders, including acoustic, aerodynamic, perceptual, and imaging data (\\\~30GB .wav/.nsp files; 135GB laryngeal videos), patient-reported outcomes (\\\~50MB REDCap exports), therapy session videos (\\\~2TB .mp4 files), and practice audio files. Core data (e.g., VHI-10 scores, voice outcomes) will be stored and shared via the Open Science Framework (OSF), adhering to NIH FAIR data principles. Files \<3MB (e.g., protocols, VHI-10 raw data) may be included in publications as appendices.
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
- ClinicalTrials.gov ID
- NCT07176988
- Acronym / sponsor ID
- STUDY00009121
- Conditions
- Dysphonia, Primary Muscle Tension Dysphonia (MTD)
- Keywords
- Conversation Training Therapy, Hierarchical Conversation Training Therapy, primary muscle tension dysphonia, benign vocal fold lesions
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Emory UniversityUniversity, hospital or other
- Collaborators
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Study start
- 3 Sep 2025 (actual)
- Primary completion
- Apr 2029 (estimated)
- Study completion
- Apr 2029 (estimated)
- First posted
- 16 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions).
The secondary objectives are:
- To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes.
- To determine the association between overall dysphonia outcomes and adoption of clear speech.
Detailed description
About 23 million Americans-roughly 1 in 13 people-suffer from voice problems at any given time. These issues can make it hard to speak clearly, lead to throat pain or fatigue, and affect daily life, work, and emotional well-being. The two most common types of voice problems are:
- Muscle tension dysphonia (MTD): when muscles in the throat are too tight during speaking.
- Benign vocal fold lesions: such as nodules or swelling on the vocal cords due to overuse or strain.
The most common treatment for these conditions is behavioral voice therapy, which involves working with a speech-language pathologist (SLP) to learn new ways to use the voice. However, over a third of patients drop out, and long-term success is uncertain. One major challenge is helping patients apply what they learn in therapy to their real-life conversations-a step often saved for the end of treatment or skipped entirely.
Traditional voice therapies often follow a strict step-by-step ("hierarchical") approach. Patients start with basic sounds or exercises and only work up to everyday speech later. But this method may not be the most effective, and many people struggle to use the new techniques outside the clinic.
To solve this problem, the research team developed a new method called Conversation Training Therapy (CTT). CTT flips the traditional approach: it begins with practicing clear, intentional speech in real conversation from the first session. This helps patients immediately apply new voice skills in real-life situations, which may lead to faster, more lasting results.
Studies have shown that CTT leads to meaningful improvements in voice-related quality of life both immediately and up to three months after therapy. It is now being used in national research studies and has gained recognition as a promising, evidence-based therapy. The current research will compare CTT to traditional methods over a full year, helping to answer important questions about what makes voice therapy work-and how to help more people benefit from it long-term.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Subjects will be assigned based on a stratified block randomization based on diagnosis (MTD, lesions), severity (mild, moderate, severe), and sex
| Arm | Type | Receives |
|---|---|---|
| Non-Hierarchical Conversation Training Therapy (CTT) | Experimental | Other: Non Hierarchical method |
| Hierarchical Conversation Training Therapy (CTT-H) | Experimental | Other: Hierarchical method |
Who may qualify
- Ages
- 16 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (7 listed)
- Non-smoking
- Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
- No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
- No history of voice therapy or voice surgery in the last year
- No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist,
Key exclusion criteria (10 listed)
- History of voice therapy or voice surgery in the last year
- Serious chronic medical condition that may affect voice (per patient report)
- Abnormal hearing ability (despite appropriate amplification)
- Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
- Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hierarchical methodParticipants in the hierarchical version of Conversation Training Therapy (CTTH) will receive four weekly sessions of voice therapy. This approach gradually increases the difficulty of speaking tasks-from simple sounds to full conversations-based on the participant's progress. The therapy begins with basic awareness and speech sounds (e.g., consonant-vowel pairs), then progresses through words, phrases, and sentences, culminating in natural conversation. Each level must be completed with at least 80% accuracy before proceeding to the next one. The structure is modeled after traditional voice therapies like resonant voice and aims to help participants succeed early and reduce mental fatigue. Daily homework includes seven short (2.5-minute) practice sessions, aligned with prior research showing this is a realistic and effective amount of practice. | Other | Hierarchical Conversation Training Therapy (CTT-H) |
| Non Hierarchical methodThe therapy includes four weekly sessions and several key techniques: Clear Speech: Speaking clearly, like leaving an important voicemail. Awareness Training: Paying attention to how the voice sounds and feels in the mouth and face. Negative Practice: Switching between their "bad" voice and "good" therapy voice to recognize and improve differences. Embedded Gestures: Briefly holding certain speech sounds to reduce vocal strain and boost clarity. Prosody and Projection: Working on pitch, rhythm, and speaking louder through better technique. Participants practice these skills throughout the day using a mobile app to track their progress and record a weekly sample. Unlike hierarchical models, components in CTT can be introduced in any order based on individual needs, making it flexible and personalized | Other | Non-Hierarchical Conversation Training Therapy (CTT) |
Primary outcome
Change in Voice Handicap Index-10 (VHI-10) score
Time frame: During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment
The Voice Handicap Index-10 (VHI-10) is a 10-question survey used to measure how much a voice problem affects a person's daily life. Scores range from 0 to 40, with higher scores indicating a greater perceived voice handicap. Each item is rated from 0 ("never") to 4 ("always") A higher score means greater voice-related disability as perceived by the patient.
Change in vowel space
Time frame: During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment.
Change in vowel space refers to alterations in the acoustic range of vowel production-specifically, how far apart vowels are from each other in the formant frequency space (typically plotted as F1 vs F2, the first and second formants). It reflects the clarity, precision, and distinctiveness of vowel articulation during speech. Vowel space will be measured through acoustic analysis of participants' spoken sentences from the Sentence Intelligibility Test (SIT). These sentences include both corner vowels (e.g., heed, had, hod, who'd) and non-corner vowels (e.g., hid, head, hut, hood), allowing for detailed tracking of articulatory patterns
13 secondary outcomes
Auditory- Perceptual severity
Time frame: Baseline , 3 month, 6 month, 12 month
Stroboscopic changes: Glottal Closure
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Amplitude
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Mucosal Wave
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Free edge contour
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Phase closure
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Phase symmetry
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Stroboscopic changes: Regularity percentage
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average airflow in speech
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average number of breaths
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Aerodynamic changes: Average speaking duration
Time frame: Baseline, Post intervention (1 week), 3 month, 6 month, 12 month
Adherence
Time frame: Baseline, end of study (12 month)
Practice fidelity
Time frame: Baseline, end of study (12 month)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2025.
- Individual participant dataSharing planned: Yes. This project will generate multi-modal data from 120 participants with voice disorders, including acoustic, aerodynamic, perceptual, and imaging data (\~30GB .wav/.nsp files; 135GB laryngeal videos), patient-reported outcomes (\~50MB REDCap exports), therapy session videos (\~2TB .mp4 files), and practice audio files. Core data (e.g., VHI-10 scores, voice outcomes) will be stored and shared via the Open Science Framework (OSF), adhering to NIH FAIR data principles. Files <3MB (e.g., protocols, VHI-10 raw data) may be included in publications as appendices.
Related trials for Dysphonia
Not yet recruiting
EMG-Guided Versus Endoscopic-Catheter Botulinum Toxin Injection for Spasmodic Dysphonia
Spasmodic Dysphonia
Active, not recruitingObservational study
Dexmedetomidine Nasal Spray and Postoperative Sore Throat After Bronchoscopy
Postoperative Sore Throat, Bronchoscopy
Not yet recruitingObservational study
Irrigation Fluid Volume, Tube Cuff Pressure, and Neck Swelling During Shoulder Arthroscopy
Shoulder Arthroscopy, Endotracheal Tube Cuff Pressure
Not yet recruitingObservational study
Effects of Video LMA Cuff Pressure in Tympanoplasty.
Oropharyngeal Leak Pressure, Airway Management
Recruiting
Intraperitoneal Dexamethasone Spraying on Vagal Nerve-Rich Areas for Prevention of Hoarseness After Upper Abdominal Surgery
Hoarseness, Post Operative Complicaiton
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Amanda Gillespie, PhD principal investigator
Emory University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hierarchical method and Non Hierarchical method in people with Dysphonia and Primary Muscle Tension Dysphonia (MTD), run by Emory University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Amanda Gillespie, PhD (404-778-3381, amanda.i.gillespie@emory.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Voice Handicap Index-10 (VHI-10) score (time frame: During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2025.